Please use this identifier to cite or link to this item: https://repository.iimb.ac.in/handle/123456789/12479
DC FieldValueLanguage
dc.contributor.advisorKenkre, Deepak
dc.contributor.authorAvinash Kumar
dc.date.accessioned2017-11-09T07:28:02Z
dc.date.accessioned2019-03-17T13:30:56Z-
dc.date.available2017-11-09T07:28:02Z
dc.date.available2019-03-17T13:30:56Z-
dc.date.issued2016
dc.identifier.urihttp://repository.iimb.ac.in/handle/123456789/12479
dc.description.abstractTwo projects are completed in the internship period in ICICI. The first project aims to develop a framework for lenders that helps them to assess the risk associated with the USFDA (regulatory authority of the US). Increasing number of inspections, pending approvals and import alerts are cause of worry for Indian pharma companies. In this context the focus is on finding out the current problems and their relevance. A checklist template is prepared that is specific to firms. The second project s aim was to compare the different technologies in solar plant and their impact on capacity utilization factor. An engineering model is developed in spreadsheet that requires the project details. The details include the module selected, losses, efficiencies, solar irradiance level, etc. Average annual generation in units (Kilo Watt hour) is calculated and capacity utilization factor (CUF) or plant load factor is calculated (PLF).
dc.language.isoen_US
dc.publisherIndian Institute of Management Bangalore
dc.relation.ispartofseriesPGP-SP-P16-02-
dc.subjectPharmaceutical industry
dc.subjectPharma companies
dc.titleUSFDA actions on Indian pharma companies and implications for lenders
dc.typeSummer Project Report-PGP
dc.pages17p.
Appears in Collections:2016
Files in This Item:
File SizeFormat 
PGP_SP_P16_02.pdf422.77 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.